Not applicableEnded earlyNCT00358098
What this trial is testing
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
Who this might be right for
Metastatic Breast Cancer
AHS Cancer Control Alberta 51